First Benelux Joint Pricing and Reimbursement Pilot Fails Over Vertex’ Orkambi

 
• By Francesca Bruce

The first pilot for the Benelux joint pricing and reimbursement process has failed. Negotiations between Vertex and the ministries of health in Belgium and the Netherlands have ended with no agreement on price for cystic fibrosis drug Orkambi.

Cystic fibrosis word cloud
Joint Pricing and Reimbursement Talks for Vertex' Cystic Fibrosis drug fail • Source: Shutterstock

More from Europe

More from Geography